{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:03:49Z","timestamp":1791975829665,"version":"4.4.0"},"reference-count":46,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Approximately 21% of patients with renal cell cancer (RCC) present with synchronous metastatic disease at the time of diagnosis, and metachronous metastatic disease occurs in 20\u201350% of cases within 5 years. Recent advances in adjuvant treatment of aggressive RCC following surgery suggest that biomarker-based prediction of risk for distant metastasis could improve patient selection. Biometrical analysis of TCGA-KIRC data identified candidate loci in the NK6 homeobox 2 gene (NKX6-2) that are hypermethylated in primary metastatic RCC. Analyses of NKX6-2 DNA methylation in three gene regions including a total of 16 CpG sites in 154 tumor-adjacent normal tissue, 189 RCC, and 194 metastatic tissue samples from 95 metastasized RCC patients revealed highly significant tumor-specific, primary metastatic-specific, and metastatic tissue-specific hypermethylation of NKX6-2. Combined CpG site methylation data for NKX6-2 and metastasis-associated genes (INA, NHLH2, and THBS4) demonstrated similarity between metastatic tissues and metastatic primary RCC tissues. The random forest method and evaluation of an unknown test cohort of tissues using receiver operator characteristic curve analysis revealed that metastatic tissues can be differentiated by a median area under the curve of 0.86 (p = 1.7 \u00d7 10\u22128\u20137.5 \u00d7 10\u22123) in 1000 random runs. Analysis of variable importance demonstrated an above median contribution for decision-making of at least one CpG site in each of the genes, suggesting superior informativity for sites annotated to NHLH2 and NKX6-2. Thus, DNA methylation of NKX6-2 is associated with the metastatic state of RCC tissues and contributes to a four-gene-based statistical predictor of tumoral and metastatic renal tissues.<\/jats:p>","DOI":"10.3390\/ijms231911190","type":"journal-article","created":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T23:13:27Z","timestamp":1664147607000},"page":"11190","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Identification of a Novel Renal Metastasis Associated CpG-Based DNA Methylation Signature (RMAMS)"],"prefix":"10.3390","volume":"23","author":[{"given":"J\u00fcrgen","family":"Serth","sequence":"first","affiliation":[{"name":"Department of Urology and Urologic Oncology, Hannover Medical School, 30625 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Peters","sequence":"additional","affiliation":[{"name":"Department of Urology and Urologic Oncology, Hannover Medical School, 30625 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Katzendorn","sequence":"additional","affiliation":[{"name":"Department of Urology and Urologic Oncology, Hannover Medical School, 30625 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tu N.","family":"Dang","sequence":"additional","affiliation":[{"name":"Department of Urology and Urologic Oncology, Hannover Medical School, 30625 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Moog","sequence":"additional","affiliation":[{"name":"Department of Urology and Urologic Oncology, Hannover Medical School, 30625 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zarife","family":"Balli","sequence":"additional","affiliation":[{"name":"Department of Urology and Urologic Oncology, Hannover Medical School, 30625 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christel","family":"Reese","sequence":"additional","affiliation":[{"name":"Department of Urology and Urologic Oncology, Hannover Medical School, 30625 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3827-6996","authenticated-orcid":false,"given":"J\u00f6rg","family":"Hennenlotter","sequence":"additional","affiliation":[{"name":"Department of Urology, University of T\u00fcbingen, 72076 T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Grote","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Hospital Gie\u00dfen und Marburg, 35043 Marburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Lafos","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hannover Medical School, 30625 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Tezval","sequence":"additional","affiliation":[{"name":"Department of Urology and Urologic Oncology, Hannover Medical School, 30625 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus A.","family":"Kuczyk","sequence":"additional","affiliation":[{"name":"Department of Urology and Urologic Oncology, Hannover Medical School, 30625 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.eururo.2018.08.036","article-title":"Epidemiology of Renal Cell Carcinoma","volume":"75","author":"Capitanio","year":"2019","journal-title":"Eur. Urol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1016\/j.clgc.2020.12.005","article-title":"Prevalence, Disease-free, and Overall Survival of Contemporary Patients With Renal Cell Carcinoma Eligible for Adjuvant Checkpoint Inhibitor Trials","volume":"19","author":"Marconi","year":"2021","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00345-016-1773-y","article-title":"Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: A population-based study","volume":"34","author":"Dabestani","year":"2016","journal-title":"World J. Urol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.euo.2018.08.023","article-title":"Clinical Stage Migration and Survival for Renal Cell Carcinoma in the United States","volume":"2","author":"Patel","year":"2019","journal-title":"Eur. Urol. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMoa2106391","article-title":"Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma","volume":"385","author":"Choueiri","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1007\/s00345-018-2309-4","article-title":"Prognostic factors and prognostic models for renal cell carcinoma: A literature review","volume":"36","author":"Klatte","year":"2018","journal-title":"World J. Urol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1200\/JCO.19.00107","article-title":"Predicting Renal Cancer Recurrence: Defining Limitations of Existing Prognostic Models With Prospective Trial-Based Validation","volume":"37","author":"Correa","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41585-018-0023-z","article-title":"Epigenetics in renal cell cancer: Mechanisms and clinical applications","volume":"15","author":"Joosten","year":"2018","journal-title":"Nat. Rev. Urol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"TCGA (2013). Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 499, 43\u201349.","DOI":"10.1038\/nature12222"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3233\/KCA-190069","article-title":"The Prognostic Value of DNA Methylation Markers in Renal Cell Cancer: A Systematic Review","volume":"4","author":"Peters","year":"2020","journal-title":"KCA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/onc.2010.525","article-title":"Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma","volume":"30","author":"Morris","year":"2011","journal-title":"Oncogene"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1158\/1078-0432.CCR-10-3394","article-title":"Analysis of promoter CpG island hypermethylation in cancer: Location, location, location!","volume":"17","author":"Niessen","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.2217\/epi-2017-0040","article-title":"Prognostic DNA methylation markers for renal cell carcinoma: A systematic review","volume":"9","author":"Joosten","year":"2017","journal-title":"Epigenomics"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.celrep.2018.03.075","article-title":"The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma","volume":"23","author":"Ricketts","year":"2018","journal-title":"Cell Rep."},{"key":"ref_15","first-page":"3861","article-title":"DNA methylation of neural EGFL like 1 (NELL1) is associated with advanced disease and the metastatic state of renal cell cancer patients","volume":"40","author":"Peters","year":"2018","journal-title":"Oncol. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3892\/or.2014.3030","article-title":"GATA5 CpG island hypermethylation is an independent predictor for poor clinical outcome in renal cell carcinoma","volume":"31","author":"Peters","year":"2014","journal-title":"Oncol. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Tezval, H., Dubrowinskaja, N., Peters, I., Reese, C., Serth, K., Atschekzei, F., Hennenlotter, J., Stenzl, A., Kuczyk, M.A., and Serth, J. (2016). Tumor Specific Epigenetic Silencing of Corticotropin Releasing Hormone -Binding Protein in Renal Cell Carcinoma: Association of Hypermethylation and Metastasis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0163873"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Katzendorn, O., Peters, I., Dubrowinskaja, N., Tezval, H., Tabrizi, P.F., Von Klot, C.A., Hennenlotter, J., Lafos, M., Kuczyk, M.A., and Serth, J. (2021). DNA methylation of tumor associated calcium signal transducer 2 (TACSTD2) loci shows association with clinically aggressive renal cell cancers. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-08172-1"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Costa, V.L., Henrique, R., Ribeiro, F.R., Pinto, M., Oliveira, J., Lobo, F., Teixeira, M.R., and Jeronimo, C. (2007). Quantitative promoter methylation analysis of multiple cancer-related genes in renal cell tumors. BMC Cancer, 7.","DOI":"10.1186\/1471-2407-7-133"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Katzendorn, O., Peters, I., Dubrowinskaja, N., Moog, J.M., Reese, C., Tezval, H., Faraj Tabrizi, P., Hennenlotter, J., Lafos, M., and Kuczyk, M.A. (2021). DNA Methylation in INA, NHLH2, and THBS4 Is Associated with Metastatic Disease in Renal Cell Carcinoma. Cancers, 14.","DOI":"10.3390\/cancers14010039"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Serth, J., Peters, I., Hill, B., H\u00fcbscher, T., Hennenlotter, J., Klintschar, M., and Kuczyk, M.A. (2022). Age-Related DNA Methylation in Normal Kidney Tissue Identifies Epigenetic Cancer Risk Susceptibility Loci in the ANKRD34B and ZIC1 Genes. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23105327"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1038\/onc.2009.493","article-title":"Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma","volume":"29","author":"Morris","year":"2010","journal-title":"Oncogene"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4161\/epi.19614","article-title":"SFRP1 CpG island methylation locus is associated with renal cell cancer susceptibility and disease recurrence","volume":"7","author":"Atschekzei","year":"2012","journal-title":"Epigenetics"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/bjc.2012.537","article-title":"Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinoma","volume":"108","author":"Gebauer","year":"2013","journal-title":"Br. J. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1158\/1078-0432.CCR-14-2049","article-title":"Promoter Methylation of CDO1 Identifies Clear-Cell Renal Cell Cancer Patients with Poor Survival Outcome","volume":"21","author":"Deckers","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1158\/1078-0432.CCR-16-1236","article-title":"A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer Patients","volume":"23","author":"Vlodrop","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/cam4.181","article-title":"Neurofilament Heavy polypeptide CpG island methylation associates with prognosis of renal cell carcinoma and prediction of antivascular endothelial growth factor therapy response","volume":"3","author":"Dubrowinskaja","year":"2014","journal-title":"Cancer Med."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Peters, I., Dubrowinskaja, N., Abbas, M., Seidel, C., Kogosov, M., Scherer, R., Gebauer, K., Merseburger, A.S., Kuczyk, M.A., and Grunwald, V. (2014). DNA methylation biomarkers predict progression-free and overall survival of metastatic renal cell cancer (mRCC) treated with antiangiogenic therapies. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0091440"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/PPO.0000000000000281","article-title":"Epigenetics and Precision Oncology","volume":"23","author":"Werner","year":"2017","journal-title":"Cancer J."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Wei, J.-H., Haddad, A., Wu, K.-J., Zhao, H.-W., Kapur, P., Zhang, Z.-L., Zhao, L.-Y., Chen, Z.-H., Zhou, Y.-Y., and Zhou, J.-C. (2015). A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma. Nat. Commun., 6.","DOI":"10.1038\/ncomms9699"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.ajhg.2017.05.009","article-title":"Mutations in NKX6-2 Cause Progressive Spastic Ataxia and Hypomyelination","volume":"100","author":"Chelban","year":"2017","journal-title":"Am. J. Hum. Genet."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1242\/dev.002691","article-title":"The transcription factors Nkx6.1 and Nkx6.2 possess equivalent activities in promoting beta-cell fate specification in Pdx1+ pancreatic progenitor cells","volume":"134","author":"Nelson","year":"2007","journal-title":"Development"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1158\/1055-9965.EPI-11-0067","article-title":"Detection of Bladder Cancer Using Novel DNA Methylation Biomarkers in Urine Sediments","volume":"20","author":"Chung","year":"2011","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Ashktorab, H., Shakoori, A., Zarnogi, S., Sun, X., Varma, S., Lee, E., Shokrani, B., Laiyemo, A.O., Washington, K., and Brim, H. (2016). Reduced Representation Bisulfite Sequencing Determination of Distinctive DNA Hypermethylated Genes in the Progression to Colon Cancer in African Americans. Gastroenterol. Res. Pract., 2016.","DOI":"10.1155\/2016\/2102674"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Pradhan, M.P., Desai, A., and Palakal, M.J. (2013). Systems biology approach to stage-wise characterization of epigenetic genes in lung adenocarcinoma. BMC Syst Biol, 7.","DOI":"10.1186\/1752-0509-7-141"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/carcin\/bgs177","article-title":"Single-CpG-resolution methylome analysis identifies clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas","volume":"33","author":"Arai","year":"2012","journal-title":"Carcinogenesis"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/eb-2012-100645","article-title":"Principles for high-quality, high-value testing","volume":"18","author":"Power","year":"2013","journal-title":"BMJ Evid.-Based Med."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Joosten, S.C., Odeh, S.N.O., Koch, A., Buekers, N., Aarts, M.J.B., Baldewijns, M.M.L.L., Van Neste, L., van Kuijk, S., Schouten, L.J., and van den Brandt, P.A. (2021). Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers. Clin. Epigenet., 13.","DOI":"10.1186\/s13148-021-01084-8"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Peters, I., Eggers, H., Atschekzei, F., Hennenlotter, J., Waalkes, S., Trankenschuh, W., Grosshennig, A., Merseburger, A.S., Stenzl, A., and Kuczyk, M.A. (2012). GATA5 CpG island methylation in renal cell cancer: A potential biomarker for metastasis and disease progression. BJU Int., 110.","DOI":"10.1111\/j.1464-410X.2011.10862.x"},{"key":"ref_40","unstructured":"(2022, July 15). R Core Team R. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. Available online: https:\/\/www.R-project.org\/."},{"key":"ref_41","unstructured":"(2022, January 05). Team, R. RStudio: Integrated Development for R. RStudio, PBC, Boston, MA. Available online: http:\/\/www.rstudio.com\/."},{"key":"ref_42","first-page":"1","article-title":"mice: Multivariate Imputation by Chained Equations in R","volume":"45","year":"2011","journal-title":"J. Stat. Softw."},{"key":"ref_43","unstructured":"(2022, July 15). R ClusterTools Package. Available online: https:\/\/github.com\/vzoche-golob\/clustertools\/blob\/master\/description."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random Forests","volume":"45","author":"Breiman","year":"2001","journal-title":"Mach. Learn."},{"key":"ref_46","unstructured":"Kuhn, M., and Wickham, H. (2022, April 01). Tidymodels: A Collection of Packages for Modeling and Machine Learning Using Tidyverse Principles. Available online: https:\/\/www.tidymodels.org."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/19\/11190\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:37:59Z","timestamp":1760143079000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/19\/11190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":46,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["ijms231911190"],"URL":"https:\/\/doi.org\/10.3390\/ijms231911190","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]}}}